Montgomery SA, Feighner JP, Sverdlov L, Shrivastava RK, Cunningham LA, Kiev A, Hlavka J, Tonelli G. Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressive disorder. The international journal of neuropsychopharmacology. Octobre 2006 9(5) 517-528. PMID16259645
Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients. International clinicat psychopharmacology. Janvier 2008 23(1) 29-35. PMID18090505
Van Der Velde CD. Rapid clinical effectiveness of MIF-I in the treatment of major depressive illness. Peptides 4(3) 297-300. doi=10.1016/0196-9781(83)90136-5. PMID6138756
Holtzheimer PE, Nemeroff CB. Novel targets for antidepressant therapies. Current psychiatry reports. Décembre 2008 10(6) 465-73. PMID18980729